{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:50:00Z","timestamp":1780973400771,"version":"3.54.1"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Angiogenesis is a multi-stage process of new blood vessel development from pre-existing vessels toward an angiogenic stimulus. The process is essential for tissue maintenance and homeostasis during embryonic development and adult life as well as tumor growth. Under normal conditions, angiogenesis is involved in physiological processes, such as wound healing, cyclic regeneration of the endometrium, placental development and repairing certain cardiac damage, in pathological conditions, it is frequently associated with cancer development and metastasis. The control mechanisms of angiogenesis in carcinogenesis are tightly regulated at the genetic and epigenetic level. While genetic alterations are the critical part of gene silencing in cancer cells, epigenetic dysregulation can lead to repression of tumor suppressor genes or oncogene activation, becoming an important event in early development and the late stages of tumor development, as well. The global alteration of the epigenetic spectrum, which includes DNA methylation, histone modification, chromatin remodeling, microRNAs, and other chromatin components, is considered one of the hallmarks of cancer, and the efforts are concentrated on the discovery of molecular epigenetic markers that identify cancerous precursor lesions or early stage cancer. This review aims to highlight recent findings on the genetic and epigenetic changes that can occur in physiological and pathological angiogenesis and analyze current knowledge on how deregulation of epigenetic modifiers contributes to tumorigenesis and tumor maintenance. Also, we will evaluate the clinical relevance of epigenetic markers of angiogenesis and the potential use of \u201cepi-drugs\u201d in modulating the responsiveness of cancer cells to anticancer therapy through chemotherapy, radiotherapy, immunotherapy and hormone therapy as anti-angiogenic strategies in cancer.<\/jats:p>","DOI":"10.3389\/fcell.2021.689962","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:38:38Z","timestamp":1630953518000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment"],"prefix":"10.3389","volume":"9","author":[{"given":"Veronica M\u00e3d\u00e3lina","family":"Aspri\u0163oiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Stoica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralia","family":"Bleotu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Cristina","family":"Diaconu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"B1","author":"Adair","year":"2010","journal-title":"Chapter 1, Overview of Angiogenesis. Angiogenesis."},{"key":"B2","first-page":"363","article-title":"Anticancer potential of curcumin: preclinical and clinical studies.","volume":"23","author":"Aggarwal","year":"2003","journal-title":"Anticancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1517\/14712598.2012.646985","article-title":"Volociximab in cancer.","volume":"12","author":"Almokadem","year":"2012","journal-title":"Expert. Opin. Biol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s10637-014-0189-z","article-title":"A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.","volume":"33","author":"Alumkal","year":"2015","journal-title":"Invest. New Drugs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.tranon.2017.04.007","article-title":"A novel neovascularization mechanism driving anti-angiogenic therapy (AAT) resistance in glioblastoma.","volume":"10","author":"Angara","year":"2017","journal-title":"Transl. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cvr\/cvq049","article-title":"Extracellular matrix, inflammation, and the angiogenic response.","volume":"86","author":"Arroyo","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis.","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.semcancer.2009.05.003","article-title":"The angiogenic switch in carcinogenesis.","volume":"19","author":"Baeriswyl","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1096\/fj.11-197400","article-title":"Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.","volume":"26","author":"Banfi","year":"2012","journal-title":"FASEB J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128878","article-title":"The vital role of blood flow-induced proliferation and migration in capillary network formation in a multiscale model of angiogenesis.","volume":"10","author":"Bazmara","year":"2015","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/srep34046","article-title":"Flow-induced HDAC1 phosphorylation and nuclear export in angiogenic sprouting.","volume":"6","author":"Bazou","year":"2016","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/1319-3767.37808","article-title":"Sorafenib in the treatment of advanced hepatocellular carcinoma.","volume":"14","author":"Ben Mousa","year":"2008","journal-title":"Saudi J. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1096\/fj.01-0651fje","article-title":"Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.","volume":"16","author":"Benelli","year":"2002","journal-title":"FASEB J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy.","volume":"8","author":"Bergers","year":"2010","journal-title":"Nat. Rev. Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","article-title":"The role of pericytes in blood-vessel formation and maintenance.","volume":"7","author":"Bergers","year":"2005","journal-title":"Neuro Oncol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00033","article-title":"A top-down view of the tumor microenvironment: structure, cells and signaling.","volume":"3","author":"Bhome","year":"2015","journal-title":"Front. Cell. Dev. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1200\/JCO.2012.41.9242","article-title":"Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.","volume":"30","author":"Bottsford-Miller","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2217\/fon.11.20","article-title":"Notch regulation of tumor angiogenesis.","volume":"7","author":"Bridges","year":"2011","journal-title":"Future Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/bjc.2017.69","article-title":"Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach.","volume":"116","author":"Bueno","year":"2017","journal-title":"Br. J. Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.1073\/pnas.182372299","article-title":"The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.","volume":"99","author":"Butler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1111\/j.1582-4934.2008.00515.x","article-title":"Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis.","volume":"12","author":"Buysschaert","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56528-2","article-title":"Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: a meta-analysis.","volume":"9","author":"Cao","year":"2019","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis.","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1570161114666160914175149","article-title":"The mir-221\/222 cluster is a key player in vascular biology via the fine-tuning of endothelial cell physiology.","volume":"15","author":"Celic","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-09-2448","article-title":"MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis.","volume":"70","author":"Cha","year":"2010","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.devcel.2009.07.011","article-title":"Local guidance of emerging vessel sprouts requires soluble Flt-1.","volume":"17","author":"Chappell","year":"2009","journal-title":"Dev. Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.","volume":"11","author":"Chen","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"B30","doi-asserted-by":"publisher","first-page":"62081","DOI":"10.18632\/oncotarget.19060","article-title":"Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival.","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1182\/blood-2007-07-104133","article-title":"Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1172\/JCI65344","article-title":"Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis.","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3892\/or.2012.2188","article-title":"Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells.","volume":"29","author":"Cheng","year":"2003","journal-title":"Oncol. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"31153","DOI":"10.18632\/oncotarget.16098","article-title":"miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway.","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"B35","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2.","volume":"103","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ydbio.2003.08.015","article-title":"Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival.","volume":"264","author":"Darland","year":"2003","journal-title":"Dev. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMcibr1309402","article-title":"Angiogenesis in glioblastoma.","volume":"369","author":"Das","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.semcancer.2007.04.001","article-title":"Dietary histone deacetylase inhibitors: from cells to mice to man.","volume":"17","author":"Dashwood","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/ATVBAHA.109.185165","article-title":"Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way.","volume":"29","author":"De Smet","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000338278","article-title":"Intussusceptive angiogenesis: a biologically relevant form of angiogenesis.","volume":"49","author":"De Spiegelaere","year":"2012","journal-title":"J. Vasc. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1182\/blood-2010-02-270819","article-title":"Identification and functional analysis of endothelial tip cell-enriched genes.","volume":"116","author":"del Toro","year":"2010","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.onc.1205108","article-title":"Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.","volume":"21","author":"Deroanne","year":"2002","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.matbio.2015.04.004","article-title":"Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.","author":"Deryugina","year":"2015","journal-title":"Matrix Biol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4962426","article-title":"MiR-222 in cardiovascular diseases: physiology and pathology.","volume":"2017","author":"Ding","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/cam4.105","article-title":"Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?","volume":"2","author":"Donnem","year":"2013","journal-title":"Cancer Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"69674","DOI":"10.18632\/oncotarget.11939","article-title":"DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1.","volume":"7","author":"Duan","year":"2013","journal-title":"Oncotarget"},{"key":"B47","author":"Duffy","year":"2000","journal-title":"Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF. Madame Curie Bioscience Database."},{"key":"B48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ncb3130","article-title":"Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome.","volume":"7","author":"Dulloo","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0006-291x(05)80280-3","article-title":"Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma.","volume":"183","author":"Eguchi","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.emboj.7600949","article-title":"EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.","volume":"25","author":"Erber","year":"2006","journal-title":"EMBO J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/a:1014027218980","article-title":"Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.","volume":"4","author":"Erg\u00fcn","year":"2010","journal-title":"Angiogenesis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/cvr\/cvw248","article-title":"The neuronal transcription factor NPAS4 is a strong inducer of sprouting angiogenesis and tip cell formation.","volume":"113","author":"Esser","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/239356","article-title":"The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration.","volume":"2014","author":"Fan","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11060-013-1223-2","article-title":"MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis.","volume":"115","author":"Fan","year":"2013","journal-title":"J. Neurooncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.3892\/mmr.2018.8620","article-title":"MicroRNA-210 promotes angiogenesis in acute myocardial infarction.","volume":"17","author":"Fan","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1074\/jbc.M800731200","article-title":"MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3.","volume":"283","author":"Fasanaro","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress.","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/70928","article-title":"Clinical applications of angiogenic growth factors and their inhibitors.","volume":"5","author":"Ferrara","year":"1999","journal-title":"Nat. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/1541-7786.MCR-11-0507","article-title":"TGF-\u03b21 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38\u03b2 to proapoptotic p38\u03b1.","volume":"10","author":"Ferrari","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity.","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00100","article-title":"The warburg effect in endothelial cells and its potential as an anti-angiogenic target in cancer.","volume":"6","author":"Fitzgerald","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0002-9440(10)64739-6","article-title":"Vasculogenic mimicry and tumor angiogenesis.","volume":"156","author":"Folberg","year":"2000","journal-title":"Am. J. Pathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1261\/rna.036467.112","article-title":"Targeting of TGF\u03b2 signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.","volume":"19","author":"Fox","year":"2013","journal-title":"RNA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.stemcr.2017.09.009","article-title":"Epigenetic activation of pro-angiogenic signaling pathways in human endothelial progenitors increases vasculogenesis.","volume":"9","author":"Fraineau","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","article-title":"Endothelial-mural cell signaling in vascular development and angiogenesis.","volume":"29","author":"Gaengel","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/ncb0808-883","article-title":"VE-cadherin and claudin-5: it takes two to tango.","volume":"10","author":"Gavard","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2147\/CMAR.S164675","article-title":"Overview of advances in vasculogenic mimicry \u2013 a potential target for tumor therapy.","volume":"10","author":"Ge","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"38095","DOI":"10.1074\/jbc.M111.257055","article-title":"HDAC4 protein regulates HIF1\u03b1 protein lysine acetylation and cancer cell response to hypoxia.","volume":"286","author":"Geng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059918","article-title":"TGF-beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.","volume":"8","author":"Geng","year":"2013","journal-title":"PLoS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J. Cell Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s1040-8428(00)00062-7","article-title":"Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis.","volume":"34","author":"Gerwins","year":"2000","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.123","article-title":"MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.","volume":"8","author":"Ghosh","year":"2017","journal-title":"Cell Death Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1042\/BST20110650","article-title":"To sprout or to split? VEGF, Notch and vascular morphogenesis.","volume":"39","author":"Gianni-Barrera","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases.","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3892\/ol.2020.11836","article-title":"Expression and clinical significance of methyl-CpG binding domain protein 2 in high-grade serous ovarian cancer.","volume":"20","author":"Gong","year":"2020","journal-title":"Oncol. Lett."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201745054","article-title":"EphrinB2\/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.","volume":"19","author":"Groppa","year":"2018","journal-title":"EMBO Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature09917","article-title":"Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase.","volume":"473","author":"Guarani","year":"2011","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","article-title":"Review article: the role of butyrate on colonic function.","volume":"27","author":"Hamer","year":"2008","journal-title":"Aliment Pharmacol. Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clon.2014.02.002","article-title":"The meaning, measurement and modification of hypoxia in the laboratory and the clinic.","volume":"26","author":"Hammond","year":"2014","journal-title":"Clin. Oncol. (R Coll. Radiol.)"},{"key":"B80","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances.","volume":"18","author":"Hao","year":"2015","journal-title":"Sensors"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00514","article-title":"Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects.","volume":"10","author":"Hassan","year":"2019","journal-title":"Front. Genet."},{"key":"B82","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/s0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbcan.2006.07.003","article-title":"Dual targeting of epigenetic therapy in cancer.","volume":"1775","author":"Hellebrekers","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"B84","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1158\/1535-7163.MCT-05-0417","article-title":"Angiostatic activity of DNA methyltransferase inhibitors.","volume":"5","author":"Hellebrekers","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1124\/jpet.117.244129","article-title":"Triple angiokinase inhibitor nintedanib directly inhibits tumor cell growth and induces tumor shrinkage via blocking oncogenic receptor tyrosine kinases an external file that holds a picture, illustration, etc.","volume":"364","author":"Hilberg","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","article-title":"Tumour vascularization: sprouting angiogenesis and beyond.","volume":"26","author":"Hillen","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","article-title":"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.","volume":"284","author":"Holash","year":"1999","journal-title":"Science"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and mmp-9 biosensors: recent advances.","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors"},{"key":"B90","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3748\/wjg.v10.i4.463","article-title":"Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.","volume":"10","author":"Huang","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1242\/jcs.03098","article-title":"Integrin ligands at a glance.","author":"Humphries","year":"2006","journal-title":"J. Cell Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jphs.2018.10.004","article-title":"Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy.","volume":"138","author":"Iizuka","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1182\/blood-2012-01-406108","article-title":"CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis.","volume":"120","author":"Jiang","year":"2012","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000190","article-title":"The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure.","volume":"4","author":"Jones","year":"2008","journal-title":"PLoS Genet."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1073\/pnas.070046397","article-title":"Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.","volume":"97","author":"Kalka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B97","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3892\/or.2012.1784","article-title":"Effects of trichostatin A on HIF-1\u03b1 and VEGF expression in human tongue squamous cell carcinoma cells in vitro.","volume":"28","author":"Kang","year":"2012","journal-title":"Oncol. Rep."},{"key":"B98","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000063781","article-title":"Differential role of bFGF and VEGF for vasculogenesis.","volume":"12","author":"Kazemi","year":"2002","journal-title":"Cell Physiol. Biochem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/86507","article-title":"Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.","volume":"7","author":"Kim","year":"2001","journal-title":"Nat. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1158\/0008-5472.CAN-03-3176","article-title":"c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.","volume":"64","author":"Knies-Bamforth","year":"2004","journal-title":"Cancer Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: good and evil.","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41374-019-0326-6","article-title":"Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis.","volume":"100","author":"Krstic","year":"2020","journal-title":"Lab Invest."},{"key":"B103","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41571-019-0181-9","article-title":"Vessel co-option in cancer.","volume":"6","author":"Kuczynski","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCRESAHA.107.153916","article-title":"Role of dicer and drosha for endothelial microRNA expression and angiogenesis.","volume":"101","author":"Kuehbacher","year":"2007","journal-title":"Circ. Res."},{"key":"B105","first-page":"341","article-title":"Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.","volume":"62","author":"K\u00fcsters","year":"2002","journal-title":"Cancer Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1101\/gad.437807","article-title":"Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis.","volume":"21","author":"Larriv\u00e9e","year":"2001","journal-title":"Genes Dev."},{"key":"B107","doi-asserted-by":"publisher","first-page":"20350","DOI":"10.1073\/pnas.0706901104","article-title":"MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.","volume":"104","author":"Lee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","article-title":"Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.","volume":"36","author":"Lee","year":"2004","journal-title":"Exp. Mol. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.18632\/oncotarget.23327","article-title":"Trichostatin A resistance is facilitated by HIF-1\u03b1 acetylation in HeLa human cervical cancer cells under normoxic conditions.","volume":"9","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00081","article-title":"Inhibition of HDAC3- and HDAC6-promoted survivin expression plays an important role in saha-induced autophagy and viability reduction in breast cancer cells.","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/onc.2017.158","article-title":"LSD1 demethylates HIF1\u03b1 to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis.","volume":"36","author":"Lee","year":"2017","journal-title":"Oncogene"},{"key":"B112","doi-asserted-by":"crossref","first-page":"33679","DOI":"10.1074\/jbc.M004994200","article-title":"Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor.","volume":"275","author":"Lee","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7150\/ijms.5011","article-title":"Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells.","volume":"9","author":"Lee","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/labinvest.2014.99","article-title":"Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.","volume":"94","author":"Lezcano","year":"2014","journal-title":"Lab Invest."},{"key":"B115","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1158\/0008-5472.CAN-14-2875","article-title":"miR-181a-5p inhibits cancer cell migration and angiogenesis via downregulation of matrix metalloproteinase-14.","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019139","article-title":"MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1\u03b1 expression.","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccr.2010.06.016","article-title":"Regulation of tumor angiogenesis by EZH2.","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"B118","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2012.05.037","article-title":"VEGF inhibits tumor cell invasion and mesenchymal transition through a MET\/VEGFR2 complex.","volume":"22","author":"Lu","year":"2012","journal-title":"Cancer Cell"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease.","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.4161\/epi.26675","article-title":"Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.","volume":"8","author":"Lyu","year":"2013","journal-title":"Epigenetics"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1172\/JCI36308","article-title":"Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models.","volume":"119","author":"Maione","year":"2009","journal-title":"Clin. Invest."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.onc.1210204","article-title":"Discovery and development of SAHA as an anticancer agent.","volume":"26","author":"Marks","year":"2007","journal-title":"Oncogene"},{"key":"B123","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","article-title":"Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.","volume":"136","author":"Mazzone","year":"2009","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00428","article-title":"MBD2 and MBD3: elusive functions and mechanisms.","volume":"5","author":"Menafra","year":"2014","journal-title":"Front. Genet."},{"key":"B125","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1159\/000430216","article-title":"LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro.","volume":"37","author":"Meng","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"B126","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo.","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/jcb.22764","article-title":"Anti-angiogenic therapy: adapting strategies to overcome resistant tumors.","volume":"111","author":"Mitchell","year":"2010","journal-title":"J. Cell Biochem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/onc.2014.2","article-title":"Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1\/2 pathway.","volume":"34","author":"Miyake","year":"2015","journal-title":"Oncogene."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00584","article-title":"Resistance to anti-angiogenic therapies: a mechanism depending on the time of exposure to the drugs front.","volume":"8","author":"Montemagno","year":"2020","journal-title":"Cell. Dev. Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1001\/jama.295.21.2516","article-title":"Sunitinib in patients with metastatic renal cell carcinoma.","volume":"295","author":"Motzer","year":"2006","journal-title":"JAMA"},{"key":"B131","doi-asserted-by":"publisher","first-page":"12444","DOI":"10.1039\/c5nr07887c","article-title":"Therapeutic application of anti-angiogenic nanomaterials in cancers.","volume":"8","author":"Mukherjee","year":"2016","journal-title":"Nanoscale"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00737","article-title":"Valproic acid induces endothelial-to-mesenchymal transition-like phenotypic switching.","volume":"9","author":"Murugavel","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs.","volume":"3","author":"Nagase","year":"2006","journal-title":"Ardiovasc. Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.hpb.2018.03.018","article-title":"Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma.","volume":"20","author":"Nakagawa","year":"2018","journal-title":"HPB"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006718","article-title":"Semaphorins in angiogenesis and tumor progression.","volume":"2","author":"Neufeld","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1101\/gad.2057811","article-title":"The diverse functions of Dot1 and H3K79 methylation.","volume":"25","author":"Nguyen","year":"2011","journal-title":"Genes Dev."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1158\/0008-5472.CAN-12-3231","article-title":"Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages.","volume":"73","author":"Osawa","year":"2013","journal-title":"Cancer Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1172\/JCI18420","article-title":"Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.","volume":"113","author":"Ozawa","year":"2004","journal-title":"Clin. Invest."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/427695a","article-title":"Pathology: cancer cells compress intratumour vessels.","volume":"427","author":"Padera","year":"2004","journal-title":"Nature"},{"key":"B140","first-page":"334","article-title":"First steps of tumor-related angiogenesis.","volume":"65","author":"Paku","year":"1991","journal-title":"Lab. Invest."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00588","article-title":"Drugs targeting epigenetic modifications and plausible therapeutic strategies against colorectal cancer.","volume":"10","author":"Patnaik","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ajpath.2019.01.010","article-title":"Methyl-CpG binding domain protein 2 inhibits the malignant characteristic of lung adenocarcinoma through the epigenetic modulation of 10 to 11 translocation 1 and miR-200s.","volume":"189","author":"Pei","year":"2019","journal-title":"Am. J. Pathol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/carcin\/23.5.735","article-title":"Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29.","volume":"23","author":"Pellizzaro","year":"2002","journal-title":"Carcinogenesis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","article-title":"Lysine-specific histone demethylase 1 (LSD1).","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.devcel.2009.01.015","article-title":"Angiogenesis: a team effort coordinated by notch.","volume":"16","author":"Phng","year":"2009","journal-title":"Dev. Cell"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1084\/jem.188.12.2349","article-title":"Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth.","volume":"188","author":"Pike","year":"1998","journal-title":"J. Exp. Med."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10080268","article-title":"The methylation status of the epigenome: its emerging role in the regulation of tumor angiogenesis and tumor growth, and potential for drug targeting.","volume":"10","author":"Pirola","year":"2018","journal-title":"Cancers"},{"key":"B148","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis.","volume":"146","author":"Potente","year":"2011","journal-title":"Cell"},{"key":"B149","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/wsbm.7","article-title":"Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products.","volume":"1","author":"Pozzi","year":"2009","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis.","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"B151","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrc2895","article-title":"The shunt problem: control of functional shunting in normal and tumour vasculature.","volume":"10","author":"Pries","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B152","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1158\/1078-0432.CCR-05-1132","article-title":"Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.","volume":"12","author":"Qian","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/ijc.26241","article-title":"Histone deacetylase inhibition as an anticancer telomerase-targeting strategy.","volume":"129","author":"Rahman","year":"2011","journal-title":"Int. J. Cancer"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1161\/CIRCULATIONAHA.110.966408","article-title":"Loss of methyl-CpG\u2013binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury.","volume":"123","author":"Rao","year":"2011","journal-title":"Circulation"},{"key":"B155","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajh.21745","article-title":"Pericytes and vessel maturation during tumor angiogenesis and metastasis.","volume":"85","author":"Raza","year":"2010","journal-title":"Am. J. Hematol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1186\/1471-2407-12-293","article-title":"Vascular endothelial growth factor production is induced by histone deacetylase 1 and suppressed by von Hippel-Lindau protein in HaCaT cells.","volume":"35","author":"Reynoso-Roldan","year":"2012","journal-title":"Clin. Invest. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cyto.2018.10.022","article-title":"Interleukins as modulators of angiogenesis and anti-angiogenesis in tumors.","volume":"118","author":"Ribatti","year":"2018","journal-title":"Cytokine"},{"key":"B158","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ydbio.2012.09.018","article-title":"\u201cSprouting angiogenesis\u201d, a reappraisal.","volume":"372","author":"Ribatti","year":"2012","journal-title":"Dev. Biol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.cb.11.110195.000445","article-title":"Annual review of cell and developmental biology.","volume":"11","author":"Risau","year":"1995","journal-title":"Vasculogenesis"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48095","article-title":"A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis.","volume":"9","author":"Rosano","year":"2020","journal-title":"Elife"},{"key":"B161","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.vph.2014.10.003","article-title":"Notch signal integration in the vasculature during remodeling.","volume":"63","author":"Rostama","year":"2014","journal-title":"Vascul. Pharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrg2295","article-title":"Epigenetic events in mammalian germ-cell development: reprogramming and beyond.","volume":"9","author":"Sasaki","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B163","doi-asserted-by":"publisher","first-page":"415","DOI":"10.18632\/aging.100176","article-title":"miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues.","volume":"2","author":"Saunders","year":"2010","journal-title":"Aging"},{"key":"B164","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature08995","article-title":"Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.","volume":"65","author":"Sawamiphak","year":"2010","journal-title":"Nature"},{"key":"B165","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.4049\/jimmunol.1500756","article-title":"Translating the untranslated region.","volume":"195","author":"Schwerk","year":"2005","journal-title":"J. Immunol."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/srep28832","article-title":"Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system.","volume":"6","author":"Seo","year":"2016","journal-title":"Sci. Rep."},{"key":"B167","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-08-0903","article-title":"Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis.","volume":"14","author":"Shankar","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1096\/fj.07-098269","article-title":"Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors.","volume":"23","author":"Sheldon","year":"2009","journal-title":"FASEB J."},{"key":"B169","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2009.23.4781","article-title":"DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes.","volume":"28","author":"Shen","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2350-2","article-title":"SET7\/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21.","volume":"11","author":"Si","year":"2020","journal-title":"Cell Death Dis."},{"key":"B171","doi-asserted-by":"publisher","first-page":"710","DOI":"10.18632\/oncotarget.205","article-title":"miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.","volume":"1","author":"Smits","year":"2010","journal-title":"Oncotarget"},{"key":"B172","doi-asserted-by":"publisher","first-page":"15342","DOI":"10.1073\/pnas.1105316108","article-title":"Fluid forces control endothelial sprouting.","volume":"108","author":"Song","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B173","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11060-013-1245-9","article-title":"MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing stathmin expression.","volume":"115","author":"Song","year":"2013","journal-title":"J. Neurooncol."},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9678098","article-title":"Exploring the drug repurposing versatility of valproic acid as a multifunctional regulator of innate and adaptive immune cells.","volume":"2019","author":"Soria-Castro","year":"2019","journal-title":"J. Immunol. Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1073\/pnas.0804597105","article-title":"Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis.","volume":"105","author":"Su\u00e1rez","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B176","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-020-03712-y","article-title":"LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.","volume":"468","author":"Sun","year":"2020","journal-title":"Mol. Cell Biochem."},{"key":"B177","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure.","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B178","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1038\/sj.onc.1206816","article-title":"Molecular basis of angiogenesis and cancer.","volume":"22","author":"Tonini","year":"2003","journal-title":"Oncogene"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood-2011-08-373886","article-title":"MicroRNA-27a\/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A.","volume":"119","author":"Urbich","year":"2012","journal-title":"Blood"},{"key":"B180","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.","volume":"48","author":"Vandooren","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0093-7754(01)90210-6","article-title":"Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy.","author":"Vaupel","year":"2001","journal-title":"Semin. Oncol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.","volume":"95","author":"von Marschall","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"B183","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2017.01.013","article-title":"CTGF promotes osteosarcoma angiogenesis by regulating miR-543\/angiopoietin 2 signaling.","volume":"391","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"B184","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3892\/or.2017.5511","article-title":"Hypoxia-induced miR-210 promoter demethylation enhances proliferation, autophagy and angiogenesis of schwannoma cells.","volume":"37","author":"Wang","year":"2007","journal-title":"Oncol. Rep."},{"key":"B185","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3892\/or.2017.5511","article-title":"Hypoxia-induced miR-210 promoter demethylation enhances proliferation, autophagy and angiogenesis of schwannoma cells.","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"B186","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/MOH.0b013e32833865d1","article-title":"Signaling circuitry in vascular morphogenesis.","volume":"17","author":"Warren","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006478","article-title":"\u03b1V integrins in angiogenesis and cancer.","volume":"1","author":"Weis","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10456-012-9291-z","article-title":"Contrasting effects of sunitinib within in vivo models of metastasis.","volume":"15","author":"Welti","year":"2012","journal-title":"Angiogenesis"},{"key":"B189","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/srao.2003.50004","article-title":"Modulation of cell death in the tumor microenvironment.","volume":"13","author":"Wouters","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ccr.2008.10.005","article-title":"miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.","volume":"14","author":"W\u00fcrdinger","year":"2008","journal-title":"Cancer Cell"},{"key":"B191","doi-asserted-by":"publisher","first-page":"91009","DOI":"10.18632\/oncotarget.18857","article-title":"TXNDC5 is a cervical tumor susceptibility gene that stimulates cell migration, vasculogenic mimicry and angiogenesis by down-regulating SERPINF1 and TRAF1 expression.","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"B192","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physiol.00029.2013","article-title":"Matrix Metalloproteinase-9: many shades of function in cardiovascular disease.","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiology"},{"key":"B193","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/15701611113119990016","article-title":"Angiogenesis-regulating microRNAs and ischemic stroke.","volume":"13","author":"Yin","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/127170","article-title":"Angiogenesis and its therapeutic opportunities.","volume":"2013","author":"Yoo","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B195","doi-asserted-by":"publisher","first-page":"98348","DOI":"10.18632\/oncotarget.21","article-title":"The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"B196","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2006.12.036","article-title":"Vasculogenic mimicry: current status and future prospects.","volume":"254","author":"Zhang","year":"2007","journal-title":"Cancer Lett."},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0334-2","article-title":"Nuclear factor 90 promotes angiogenesis by regulating HIF-1\u03b1\/VEGF-A expression through the PI3K\/Akt signaling pathway in human cervical cancer.","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"B198","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2017.03.022","article-title":"miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer.","volume":"615","author":"Zhang","year":"2017","journal-title":"Gene"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.18632\/oncotarget.2748","article-title":"miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3\/VEGF-A pathway in gastric cancer.","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"B200","doi-asserted-by":"publisher","first-page":"9859","DOI":"10.18632\/oncotarget.7126","article-title":"The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B201","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2174\/092986711797200426","article-title":"Hypoxia Inducible Factor-1 as a target for neurodegenerative diseases.","volume":"18","author":"Zhang","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/jnen\/nlx088","article-title":"LBH589 Inhibits glioblastoma growth and angiogenesis through suppression of HIF-1\u03b1 expression.","volume":"76","author":"Zhi-Gang","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.3892\/ol.2017.7260","article-title":"Human thymic stromal lymphopoietin promotes the proliferation and invasion of cervical cancer cells by downregulating microRNA-132 expression.","volume":"14","author":"Zhou","year":"2017","journal-title":"Oncol. Lett."},{"key":"B204","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1158\/0008-5472.CAN-11-1157","article-title":"Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.","volume":"71","author":"Zhu","year":"2011","journal-title":"Cancer Res."},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00248","article-title":"Unraveling the role of angiogenesis in cancer ecosystems.","volume":"8","author":"Zuazo-Gaztelu","year":"2018","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.689962\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:38:48Z","timestamp":1630953528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.689962\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":205,"alternative-id":["10.3389\/fcell.2021.689962"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.689962","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"article-number":"689962"}}